Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Net Margin (2016 - 2025)

Historic Net Margin for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to 208.39%.

  • Regenxbio's Net Margin rose 380100.0% to 208.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 110.38%, marking a year-over-year increase of 1731000.0%. This contributed to the annual value of 272.54% for FY2024, which is 194500.0% up from last year.
  • As of Q3 2025, Regenxbio's Net Margin stood at 208.39%, which was up 380100.0% from 331.91% recorded in Q2 2025.
  • Regenxbio's 5-year Net Margin high stood at 73.75% for Q4 2021, and its period low was 405.63% during Q1 2024.
  • Its 5-year average for Net Margin is 239.22%, with a median of 246.4% in 2024.
  • As far as peak fluctuations go, Regenxbio's Net Margin tumbled by -2649600bps in 2022, and later soared by 4124300bps in 2025.
  • Quarter analysis of 5 years shows Regenxbio's Net Margin stood at 73.75% in 2021, then crashed by -359bps to 191.21% in 2022, then crashed by -48bps to 283.8% in 2023, then grew by 15bps to 241.68% in 2024, then grew by 14bps to 208.39% in 2025.
  • Its Net Margin was 208.39% in Q3 2025, compared to 331.91% in Q2 2025 and 6.81% in Q1 2025.